8.66

3.46% 0.28

Adicet Bio Inc (ACET)

Overview News Price History Option Chain Financials Discussions Forecast

Adicet Bio Inc stock is traded at $8.66, with a volume of 75,170. It is up +3.46% in the last 24 hours and up +6.77% over the past month. Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).

Previous Close:

$8.38

Open:

$8.46

24h Volume:

75,170

Relative Volume:

0.80

Market Cap:

$81.82M

Revenue:

$24.99M

Net Income/Loss:

$-108.83M

P/E Ratio:

-0.5762

EPS:

-15.0286

Net Cash Flow:

$-91.62M

1W Performance:

+6.91%

1M Performance:

+6.77%

6M Performance:

+23.15%

1Y Performance:

-17.27%

1-Day Range:

$8.46

$8.99

1-Week Range:

$7.925

$8.99

52-Week Range:

$6.01

$17.44

Adicet Bio Inc Stock (ACET) Company Profile

Name

Adicet Bio Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

617-482-2333

Address

131 DARTMOUTH STREET, BOSTON

Employee

102

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

ACET's Discussions on Twitter

Compare ACET vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ACET Adicet Bio Inc	8.74	78.45M	24.99M	-108.83M	-91.62M	-15.03
VRTX Vertex Pharmaceuticals Inc	515.89	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.79	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.63	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.22	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.16	39.31B	5.76B	514.49M	1.10B	4.4813

Adicet Bio Inc Stock (ACET) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-30-24	Resumed	Guggenheim	Buy
Sep-11-24	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-27-23	Downgrade	Guggenheim	Buy → Neutral
Jun-27-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-01-23	Downgrade	JP Morgan	Overweight → Neutral
Sep-21-22	Initiated	JP Morgan	Overweight
Mar-31-22	Initiated	SMBC Nikko	Outperform
Mar-08-22	Initiated	Truist	Buy
Mar-04-22	Initiated	Jefferies	Buy
May-18-21	Initiated	BTIG Research	Buy
Apr-23-21	Initiated	H.C. Wainwright	Buy
Apr-14-21	Initiated	Canaccord Genuity	Buy
Apr-08-21	Initiated	Guggenheim	Buy
Nov-04-20	Initiated	B. Riley Securities	Buy
Oct-27-20	Initiated	JMP Securities	Mkt Outperform
Oct-16-20	Initiated	Wedbush	Outperform

View All

Adicet Bio Inc Stock (ACET) Latest News

Aug 14, 2026

RA Capital discloses 9.99% Adicet Bio (ACET) stake with warrant blocker - Stock Titan

Aug 14, 2026

Adicet Bio: A Cheap Gamma Delta T-Cell Play (NASDAQ:ACET) - Seeking Alpha

Aug 14, 2026

Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet - Zacks Investment Research

Aug 14, 2026

Aug 12, 2026

Adicet Bio (ACET) Edges Higher to $8.26 as Biotech Stock Consolidates Between Key LevelsVanna Flow - dars.gov.et

Aug 12, 2026

HC Wainwright Has Strong Estimate for Adicet Bio Q3 Earnings - MarketBeat

Aug 12, 2026

Aug 11, 2026

Adicet Bio at Canaccord Genuity: lupus data drives next step By Investing.com - Investing.com Canada

Aug 11, 2026

Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy - MarketBeat

Aug 11, 2026

All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy - newsbreak.com

Aug 11, 2026

Aug 10, 2026

H.C. Wainwright Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $27 - Moomoo

Aug 10, 2026

Aug 07, 2026

JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $20 - Moomoo

Aug 07, 2026

Price to sales forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView

Aug 07, 2026